Another pedigree with familial acute myeloid leukemia and germline CEBPA mutation

Leukemia

Volumn 23, Issue 4, 2009, Pages 804-806

  Renneville, A ^a,e   Mialou, V ^b   Philippe, N ^a   Kagialis Girard, S ^c   Biggio, V ^a   Zabot, M T ^d   Thomas, X ^c   Bertrand, Y ^b   Preudhomme, C ^a,e  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d Centre de Biologie Est   (France)

^e Institut de Recherche sur le Cancer de Lille   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT; CCAAT ENHANCER BINDING PROTEIN ALPHA; CD135 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD65 ANTIGEN; CD7 ANTIGEN; GENOMIC DNA; HLA DR ANTIGEN; K RAS PROTEIN; LYMPHOCYTE ANTIGEN; MICROSOMAL AMINOPEPTIDASE; STEM CELL FACTOR; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANAMNESIS; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLAST CELL; BONE MARROW; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RELAPSE; CASE REPORT; CELL INFILTRATION; CHILD; CHROMOSOME ANALYSIS; CORD BLOOD STEM CELL TRANSPLANTATION; DNA EXTRACTION; DNA SEQUENCE; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE IDENTIFICATION; GENE INSERTION; GENETIC SCREENING; GERM LINE; HEREDITY; HUMAN; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MALE; MOTHER CHILD RELATION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PEDIGREE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 64849093213     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.294     Document Type: Article

References (9)

1. Leroy H, Roumier C, Huyghe P, Biggio V, Fenaux P, Preudhomme C. CEBPA point mutations in hematological malignancies. Leukemia 2005; 19: 329-334.
2. Smith ML, Cavenagh JD, Lister TA, Fitzgibbon J. Mutation of CEBPA in familial acute myeloid leukemia. N Engl J Med 2004; 351: 2403-2407.
3. Sellick GS, Spendlove HE, Catovsky D, Pritchard-Jones K, Houlston RS. Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia. Leukemia 2005; 19: 1276-1278.
4. Nanri T, Uike N, Kawakita T, Iwanaga E, Hoshino K, Mitsuya H et al A pedigree harboring a germ-line N-terminal C/EBPα mutation and development of acute myeloblastic leukemia with a somatic C-terminal C/ EBPα mutation. Blood 2006; 108: 543a (abstract 1916).
5. Corbacioglu A, Fröhling S, Mendla C, Eiwen K, Habdank M, Döhner H et al. Germline mutation screening in cytogenetically normal acute myeloid leukemia with somatically acquired CEBPA mutations. Blood 2007; 110: 114a (abstract 363).
6. Owen C, Barnett M, Fitzgibbon J. Familial myelodysplasia and acute myeloid leukaemia-a review. Br J Haematol 2008; 140: 123-132.
7. Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 2001; 27: 263-270.
8. Kirstetter P, Schuster MB, Bereshchenko O, Moore S, Dvinge H, Kurz E et al. Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer Cell 2008; 13: 289-291.
9. Biggio V, Renneville A, Nibourel O, Philippe N, Terriou L, Roumier C, et al., French ALFA group. Recurrent in-frame insertion in C/EBPalpha TAD2 region is a polymorphism without prognostic value in AML. Leukemia 2008; 22: 655-657.